These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3021732)

  • 1. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ; Veerman H; Pannekoek H
    J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
    J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
    Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator.
    Bakker AH; van der Greef W; Rehberg EF; Marotti KR; Verheijen JH
    J Biol Chem; 1993 Sep; 268(25):18496-501. PubMed ID: 8395505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
    Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain.
    Váli Z; Patthy L
    J Biol Chem; 1984 Nov; 259(22):13690-4. PubMed ID: 6094526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.
    Gething MJ; Adler B; Boose JA; Gerard RD; Madison EL; McGookey D; Meidell RS; Roman LM; Sambrook J
    EMBO J; 1988 Sep; 7(9):2731-40. PubMed ID: 2846282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.
    Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
    Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
    EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
    Langer-Safer PR; Ahern TJ; Angus LB; Barone KM; Brenner MJ; Horgan PG; Morris GE; Stoudemire JB; Timony GA; Larsen GR
    J Biol Chem; 1991 Feb; 266(6):3715-23. PubMed ID: 1847387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot.
    Bakker AH; Weening-Verhoeff EJ; Verheijen JH
    J Biol Chem; 1995 May; 270(21):12355-60. PubMed ID: 7759476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
    de Vries C; Veerman H; Koornneef E; Pannekoek H
    J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M; Fredenburgh JC; Larsen GR
    J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin.
    de Vries C; Veerman H; Pannekoek H
    J Biol Chem; 1989 Jul; 264(21):12604-10. PubMed ID: 2526127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Kaneko M; Sakata Y; Matsuda M; Mimuro J
    J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.